Similarweb Ltd.
8.04USD
-0.3400 (-4.06%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.08▲ | $0.05 | 7 | 0 |
| Next quarter | $0.07▲ | $0.06 | 7 | 1 |
| Current year | $0.21▲ | $0.14 | 8 | 0 |
| Next year | $0.31▲ | $0.24 | 7 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.03 | $0.06 | +0.03 (+97.6%) |
| 2026-03-31 | $0.02 | $0.01 | -0.01 (-59.3%) |
| 2025-12-31 | $0.03 | $0.03 | +0.00 (+12.5%) |
| 2025-09-30 | $0.02 | $0.05 | +0.03 (+187.7%) |
41 ratings from 11 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | $7 $9 | Aug 13, 2026 |
| Barclays | Maintained | Overweight | $5 $11 | Aug 13, 2026 |
| Northland Capital Markets | Upgraded from Market Perform | Outperform | $5 $10 | Aug 12, 2026 |
| Oppenheimer | Maintained | Outperform | $7 $8.5 | Aug 5, 2026 |
| Citigroup | Maintained | Neutral | $3 $7 | Jul 9, 2026 |
| Oppenheimer | Maintained | Outperform | $4 $7 | Jun 18, 2026 |
| Barclays | Maintained | Overweight | $7 $5 | Apr 21, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $8.5 $3 | Apr 10, 2026 |
| Citigroup | Maintained | Buy | $11 $8.5 | Feb 20, 2026 |
| Oppenheimer | Maintained | Outperform | $7 $4 | Feb 19, 2026 |
| Needham | Downgraded from Buy | Hold | — | Feb 19, 2026 |
| William Blair | Downgraded from Outperform | Market Perform | — | Feb 18, 2026 |
| Citizens | Downgraded from Market Outperform | Market Perform | — | Feb 18, 2026 |
| Oppenheimer | Maintained | Outperform | $10 $7 | Feb 4, 2026 |
| Barclays | Maintained | Overweight | $12 $10 | Jan 12, 2026 |
| Oppenheimer | Maintained | Outperform | $12 $10 | Dec 17, 2025 |
| Needham | Reiterated | Buy | $14 | Nov 17, 2025 |
| Oppenheimer | Maintained | Outperform | $13 $14 | Aug 18, 2025 |
| Citigroup | Maintained | Buy | $13 $11 | Aug 1, 2025 |
| Barclays | Maintained | Overweight | $15 $10 | May 15, 2025 |
| Goldman Sachs | Maintained | Buy | $13 $10 | Apr 17, 2025 |
| Goldman Sachs | Maintained | Buy | $15 $13 | Mar 28, 2025 |
| JMP Securities | Reiterated | Market Outperform | $17 | Feb 13, 2025 |
| Needham | Reiterated | Buy | $14 | Feb 13, 2025 |
| Citigroup | Maintained | Buy | $14 $22 | Feb 11, 2025 |
9 filings from 4 insiders · 7 buy / 2 sell over 6m
Officers and directors of SMWB, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| OFFER ORChief Executive Officer | Exercise | 383.1k | $0.40 | $994k | Aug 26, 2026 |
| OFFER ORChief Executive Officer | Sell | 383.1k | $9.00 | $3.45M | Aug 26, 2026 |
| OFFER ORChief Executive Officer | Exercise | 563.5k | $0.40 | $987k | Aug 14, 2026 |
| OFFER ORChief Executive Officer | Sell | 709.6k | $8.75 | $6.26M | Aug 14, 2026 |
| OFFER ORChief Executive Officer | Buy | 50.0k | $4.15 | $208k | Jun 1, 2026 |
| EILAM BARAKDirector | Buy | 50.0k | $3.86 | $193k | May 21, 2026 |
| BEIT-ON HARELDirector | Buy | 75.0k | $3.89 | $292k | May 20, 2026 |
| OFFER ORChief Executive Officer | Buy | 56.1k | $3.20 | $200k | May 19, 2026 |
| RAPAPORT DAGIM TAMARDirector | Buy | 40.0k | $3.22 | $129k | May 18, 2026 |
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 3 | 4 | 0 | 0 | Buy2.38 |
| 1 mo ago | 1 | 3 | 4 | 0 | 0 | Buy2.38 |
| 2 mo ago | 1 | 2 | 5 | 0 | 0 | Hold2.50 |
| 3 mo ago | 1 | 2 | 5 | 0 | 0 | Hold2.50 |